Healthcare organizations are increasing their efforts to contain medication non-adherence costs by concentrating on care transitions in complex patients, according to the results of HIN’s third annual Medication Adherence e-survey. More than half of responding organizations said they are targeting this vulnerable population where a majority of gaps in care can occur.
Medication non-adherence costs are estimated at $290 billion in ‘otherwise avoidable medical spending’ in the United States alone each year. In its third annual Medication Adherence e-survey conducted in January 2013, the Healthcare Intelligence Network captured emerging trends in efforts to improve medication adherence (MA). More than 100 healthcare organizations described program components, key stakeholders, supporting tools and technology, and results and ROI.
Complex patients and those taking multiple medications remain the most common targets of medication adherence (MA) programs, say 75 percent of respondents. But meriting more attention this year are MA levels in those transitioning from one care site to another, when gaps in care can occur. More than half of responding MA programs (54 percent) target this vulnerable population, up from 37 percent last year. This increase may explain why the hospital discharge and the home visit — key transition points — are more popular opportunities to dispense medication adherence information for this year’s respondents than for last year’s.
The use of MA assessment tools such as the REALM-R, Medication Knowledge Survey and CMS OASIS Data Set has doubled and in some cases quadrupled over the last year.
While the presence of a pharmacist on the MA team remained constant from 2012 to 2013 at 65 percent, there are more retail or community pharmacists on the MA scene today — 53 percent in 2013 versus 48 percent in 2012. The use of e-prescribing also rose from 19 percent to 26 percent in the last year.
2013 Healthcare Benchmarks: Improving Medication Adherence provides actionable information from more than 100 healthcare organizations on efforts to improve medication adherence and compliance in their populations, and documents the impact of these programs on adherence and compliance levels, medication costs, ER visits, hospital and skilled nursing facility admissions, risk of death, and other areas of concern.